ID   DM382
AC   CVCL_IS49
SY   Duke Melanoma 382
DR   GEO; GSM276751
DR   Wikidata; Q54831222
RX   PubMed=9241074;
CC   From: Duke University Medical Center; Durham; USA.
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 6
//
RX   PubMed=9241074; DOI=10.1002/(SICI)1097-0142(19970801)80:3<401::AID-CNCR8>3.0.CO;2-U;
RA   Abdel-Wahab Z., Weltz C., Hester D., Pickett N., Vervaert C.,
RA   Barber J.R., Jolly D.J., Seigler H.F.;
RT   "A phase I clinical trial of immunotherapy with interferon-gamma
RT   gene-modified autologous melanoma cells: monitoring the humoral immune
RT   response.";
RL   Cancer 80:401-412(1997).
//